The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment

Neurobiology of Aging

Volumn 28, Issue 4, 2007, Pages 515-518

  Giunta, M ^a   Rigamonti, A E ^a   Scarpini, E ^a   Galimberti, D ^a   Bonomo, S M ^a   Venturelli, E ^a   Muller E E ^a   Cella, S G ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; CD36; Leukocytes; MCI

Indexed keywords

AMYLOID BETA PROTEIN; CD36 ANTIGEN; SCAVENGER RECEPTOR B;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MICROGLIA; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADULT; AGE FACTORS; AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANTIGENS, CD36; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33847204688     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.02.002     Document Type: Article

References (28)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
2. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., and Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42 (1992) 631-639
3. Christie R.H., Freeman M., and Hyman B.T. Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am J Pathol 148 (1996) 399-403
4. Coraci I.S., Husemann J., Berman J.W., Hulette C., Dufour J.H., Campanella G.K., et al. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am J Pathol 160 (2002) 101-112
5. Dawe B., Procter A., and Philpot M. Concepts of mild cognitive impairment in the elderly and their relationship to dementia: a review. Int J Geriatr Psychiatry 7 (1992) 473-479
6. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., and Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382 (1996) 716-719
7. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., and Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268 (1993) 11811-11816
8. Flicker C., Ferris S.H., and Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41 (1991) 1006-1009
9. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
10. Gauthier S., and Touchon J. Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 62 (2005) 1164-1166
11. Hori T., Nakashima T., Take S., Kaizuka Y., Mori T., and Katafuchi T. Related Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 27 (1991) 309-313
12. Husemann J., and Silverstein S.C. Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain. Am J Pathol 158 (2001) 825-832
13. Jack Jr. C.R., Petersen R.C., Xu Y.C., O'Brien P.C., Smith G.E., Ivnik R.J., et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52 (1999) 1397-1403
14. 2. J Exp Med 188 (1998) 2257-2265
15. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
16. Medeiros L.A., Khan T., El Khoury J.B., Pham C.L., Hatters D.M., Howlett G.J., et al. Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J Biol Chem 279 (2004) 10643-10648
17. Moore K.J., El Khoury J., Medeiros L.A., Terada K., Geula C., Luster A.D., et al. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem 277 (2002) 47373-47379
18. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., et al. Mild cognitive impairment represents early-stage Alzheimer's disease. Arch Neurol 58 (2001) 397-405
19. Ohgami N., Nagai R., Ikemoto M., Arai H., Miyazaki A., Hakamata H., et al. CD36 serves as a receptor for advanced glycation endproducts (AGE). J Diabetes Complications 16 (2002) 56-59
20. Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N., et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273 (1995) 1274-1278
21. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 (1999) 303-308
22. Petersen R.C. Normal aging, mild cognitive impairment, and early Alzheimer's disease. Neurologist 1 (1995) 326-344
23. Ricciarelli R., D'Abramo C., Zingg J.M., Giliberto L., Markesbery W., Azzi A., et al. CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease. Free Radic Biol Med 36 (2004) 1018-1024
24. Rigamonti AE, Bonomo SM, Scanniffio D, Cella SG, Muller EE. Orexigenic effects of GHS and nitric oxide in aged rats: correlation with the hypothalamic expression of some neuropeptidergic/receptoral effectors mediating food-intake. J Gerontol, in press.
25. Schlageter N.L., Carson R.E., and Rapoport S.I. Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography. J Cereb Blood Flow Metab 7 (1987) 1-8
26. Shah Y., Tangalos E.G., and Petersen R.C. Mild cognitive impairment: when is it a precursor to Alzheimer's disease?. Geriatrics 55 (2000) 62-68
27. Sunderland T., Gur R.E., and Arnold S.E. The use of biomarkers in the elderly: current and future challenges. Biol Psychiatry 58 (2005) 272-276
28. Yamada Y., Doi T., Hamakubo T., and Kodama T. Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system. Cell Mol Life Sci 54 (1998) 628-640